PUBLISHED DATE : Dec 2022 | Pages : 238
Fill out your details & get your free sample
The Global Biocatalysts Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
238 Pages
119 Tables
81 Charts
5 Regions
18 Countries
19 Companies
3 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 729.03 Million |
| Market Size (2021) | USD 495 Million |
| CAGR (2021-2027) | 6.67% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Type, End Use, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Key Players | DuPont, BASF SE, DSM, AB Enzymes, and Novozymes |
The global biocatalysts market is expected to cross USD 729.03 million by 2027, from USD 495 million in 2021, growing at a CAGR of 6.67% from 2022-2027. Biocatalysts are substances, specifically enzymes, that activate or speed up a biochemical reaction. Biocatalysts are used in chemical synthesis in various industries (such as pharmaceuticals, food & beverages, animal nutrition, household, and others). In the pharmaceutical industry, biocatalysts help in manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments.
Increasing demand for biobased products drives the biocatalysts market. Due to emerging technology, sustainability is growing all over the world. In the pharmaceutical industry, companies have started using biobased drugs to improve the quality of products, making the pharmaceutical biocatalysts market grow rapidly. Thus, top companies follow the expansion strategy to acquire a greater biocatalysts market share. The food & beverages industry is rising due to the increasing consumption of food & beverages, thus increasing the demand for biocatalysts in the global industry.
Increase in Food Consumption Due to Growth in Population
The food industry includes four major sectors - producers, marketers, processors, and farm services. During the Covid 19, the demand for food supplies increased, resulting in the food industry's growth. Enzymes are used in the food industry as a preservative, the best substitute for chemical preservatives. They improve the quality of products such as starch, fruit juices, cheese, animal feed, and beer & wine. From the application perspective, the demand for animal feed is increasing due to higher poultry, meat, and dairy consumption.
Increasing Demand from Pharmaceutical Industry
The pharmaceutical industry’s revenue is increasing yearly due to increasing demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues.
The lowering of regulatory barriers for new drugs in the US causes an increased demand for pharma sector products globally. During the Covid-19 pandemic, the highest demand for pharmaceutical products was observed. The demand for new drugs is still high owing to the recurrence of new variants of Covid-19 in various countries. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of Covid-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And with a growing global pharmaceutical industry, the biocatalysts market is also growing.
Technical Barriers Affecting Industry
Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, biocatalysts play an important role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of biocatalysts. The process is time-consuming and requires more catalysts to fulfilling the chemical reaction process. For the biocatalysts manufacturing process, specific conditions such as new substrate, new concentration, and other conditions are required which are not found easily in nature. Thus, increasing the cost of producing the biocatalysts.
INSIGHTS BY TYPE
Carbohydrases is the largest segment by type in the global biocatalysts market and is expected to reach USD 231.03 million by 2027. Carbohydrases are mainly used in the food industry as biocatalysts. Most of these biocatalysts used in the food industry are produced from fungi, yeast, and bacteria. Carbohydrases are used in milk products as digestion agents to reduce milk lactose. These are further classified into alpha, beta amylases, cellulases, glucosidase, pectinases, mannanases, galacto, and pullulanase.
The global proteases-based biocatalysts market was valued at USD 134.40 million in 2021 and is the second largest industry by type segment. The proteases are used in the cleaning, leather, and dairy industries. Based on the catalysis mechanism, the proteases are classified into further classes glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
Lipases are used in the catalysis of fats, which helps reduce their food content. These are derived from animal and plant enzymes used in various biological processes, which are used for inflammation, diet, and increasing metabolism. The lipases segment is expected to grow at a CAGR of 6.54% during the forecast period. These are used in esters and have high scope in biofuels. The increased demand for biofuels is due to the increasing prices of crude oil, which further increases the demand for lipases in the biocatalysts markets.
INSIGHTS BY END-USE
The global biocatalysts market by end-use is categorized as pharmaceutical, food & beverages, animal nutrition, household, and others. The pharmaceutical is the largest segment by end-use and is expected to cross USD 215.42 million by 2027. Due to the growth in the global population, the demand for pharmaceutical products is increasing. Due to people becoming more health conscious, pharmaceutical companies are focusing on increasing the bio-based content in drug formulations. In the pharmaceutical industry, biocatalysts are used for molecular biology, extraction of medically important compounds, diagnostic procedures, chemical pharmaceutical manufacturing, and deficiencies supplements.
The food & beverages segment is growing with a CAGR of 7.52 % during the forecast period and is the second largest segment by end-use. Biocatalysts have been used for hundreds of years in the food & beverages industry. Commercial biocatalysts are produced from microbial, plants, and animals. There is a massive demand for bakery biocatalysts in the industry for extended shelf life, mainly in Europe and North America. Biocatalyst manufacturing companies are developing new designs to improve bakery food quality.
North America dominates the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. The region is the leading market for biocatalysts because of its rapidly developing infrastructure, readily increasing population, and growing demand from various industries such as food & beverage, pharmaceutical, animal nutrition, and household. The US and Canada are the two major countries dominating North America’s biocatalyst market. The demand for biocatalysts in North America's pharmaceutical industry is increasing with the rise in pharma products and the presence of the world-leading ten pharmaceutical companies in the US.
The APAC biocatalysts market is the second largest industry globally and is expected to grow the highest CAGR during the forecast period. With the changing technology & innovations in food & beverages, the demand for biocatalysts is increasing. Increasing health expenditure, increasing health consciousness, increasing new diseases, and others are the key factors for the growing pharmaceutical market, further contributing to the Asia Pacific industry.
Germany, Italy, France, and Spain are the major countries in the European biocatalyst market. The increasing consumption of biocatalysts is attributed to the rising per capita income in European countries. High spending on healthy food, attributed to people's health-conscious habits, and growing demand for food & beverages biocatalysts are significant market drivers in Europe.
Some key players in the global biocatalysts market include DuPont (U.S.), AB Enzymes (Germany), BASF SE (Germany), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies such as expansion, acquisitions, new product development, joint ventures, and others to increase their revenues in the biocatalysts market. Furthermore, other prominent companies such as Amano Enzymes (Japan), Dyadic International (U.S.), Codexis (U.S.), and others have invested considerable capital in R&D to develop biocatalysts-based products that will appeal to the customers. Therefore, these other prominent companies are giving tough competition to major companies.
The major companies follow a merger and acquisition strategy, giving them a competitive advantage to boost their market share. The key vendors have undertaken various strategies to grow in the global biocatalysts market. The growth in sustainable processes and innovations has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable biocatalysts products.
Key Developments In The Global Biocatalysts Market:
Frequently Asked Questions
What is the revenue from the global biocatalysts market?
The global biocatalysts market was valued at USD 495 million in 2021.
What is the growth rate of the biocatalysts market?
The global biocatalysts market share is expected to grow at a CAGR of 5.60% from 2022 to 2027.
Who are the key players in the global biocatalysts market?
DuPont, BASF SE, DSM, AB Enzymes, and Novozymes are the key players in the global biocatalysts market.
What is the projected biocatalysts market by 2027?
The global biocatalysts market size is expected to reach USD 729.03 million by 2027.
What are the key driving factors in the global biocatalysts market?
Increasing demand from the pharmaceutical industry, soaring demand for biofuels, and adopting sustainability standards to improve productivity and profitability are some key trends in the global biocatalysts market.
Which region dominates the global biocatalysts Market?
North America is dominating the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. With the increasing health consciousness in US & Canada, people's demand for bio-based product’s increasing. The US is a developed country where people are aware of diet & healthy food products, so the demand for biocatalysts used in food & beverages is very high, contributing to the industry’s growth.
The biocatalysts market is expected to grow at a CAGR of approximately 6.67% from 2022 to 2027.
The following factors are likely to contribute to the growth of the global biocatalysts market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the global biocatalysts market and its market dynamics for 2022−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Type
Segmentation by End Use
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 INTRODUCTION
6.2 MARKET SYNOPSIS
6.2.1 ENABLER
6.2.2 OPPORTUNITIES
6.2.3 RESTRAINT
6.3 SEGMENT REVIEW
6.3.1 END-USERS
6.3.2 TYPE
6.4 GEOGRAPHY
6.5 COMPANIES AND STRATEGIES
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
8.2 VALUE CHAIN ANALYSIS
8.2.1 RAW MATERIALS
8.2.2 BIOCATALYST MANUFACTURER
8.2.3 DISTRIBUTOR
8.2.4 APPLICATION
8.3 MACROECONOMIC FACTORS
8.3.1 PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES
8.3.2 FOOD & BEVERAGES INDUSTRY
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
9.2 SOARING DEMAND FOR BIOFUEL
9.3 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
9.4 INCREASING USE OF CLEANING PRODUCTS
10 MARKET GROWTH ENABLERS
10.1 INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
10.2 RISE IN DEMAND FOR PLANT-BASED PRODUCTS
11 MARKET GROWTH RESTRAINTS
11.1 TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
11.2 HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CARBOHYDRASES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 PROTEASES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 POLYMERASES & NUCLEASES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 LIPASES
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 PHYTASES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
13.8 OTHERS
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 MARKET BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMACEUTICAL
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 FOOD & BEVERAGES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 ANIMAL NUTRITION
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 HOUSEHOLD
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 TYPE
16.3.1 MARKET SIZE & FORECAST
16.4 END-USER
16.4.1 MARKET SIZE & FORECAST
16.5 KEY COUNTRIES
16.6 US
16.6.1 MARKET SIZE & FORECAST
16.7 CANADA
16.7.1 MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TYPE
17.3.1 MARKET SIZE & FORECAST
17.4 END-USER
17.4.1 MARKET SIZE & FORECAST
17.5 KEY COUNTRIES
17.6 GERMANY
17.6.1 MARKET SIZE & FORECAST
17.7 FRANCE
17.7.1 MARKET SIZE & FORECAST
17.8 ITALY
17.8.1 MARKET SIZE & FORECAST
17.9 SPAIN
17.9.1 MARKET SIZE & FORECAST
17.10 REST OF EUROPE
17.10.1 MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 END-USER
18.4.1 MARKET SIZE & FORECAST
18.5 KEY COUNTRIES
18.6 CHINA
18.6.1 MARKET SIZE & FORECAST
18.7 INDIA
18.7.1 MARKET SIZE & FORECAST
18.8 JAPAN
18.8.1 MARKET SIZE & FORECAST
18.9 SOUTH KOREA
18.9.1 MARKET SIZE & FORECAST
18.10 REST OF APAC
18.10.1 MARKET SIZE & FORECAST
19 MIDDLE EAST & AFRICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 END-USER
19.4.1 MARKET SIZE & FORECAST
19.5 KEY COUNTRIES
19.6 SAUDI ARABIA
19.6.1 MARKET SIZE & FORECAST
19.7 SOUTH AFRICA
19.7.1 MARKET SIZE & FORECAST
19.8 REST OF MIDDLE EAST & AFRICA
19.8.1 MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 END-USER
20.4.1 MARKET SIZE & FORECAST
20.5 KEY COUNTRIES
20.6 BRAZIL
20.6.1 MARKET SIZE & FORECAST
20.7 MEXICO
20.7.1 MARKET SIZE & FORECAST
20.8 REST OF LATIN AMERICA
20.8.1 MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
22 KEY COMPANY PROFILES
22.1 DUPONT
22.1.1 BUSINESS OVERVIEW
22.1.2 FINANCIAL OVERVIEW
22.1.3 PRODUCT OFFERINGS
22.1.4 KEY STRATEGIES
22.1.5 KEY STRENGTHS
22.1.6 KEY OPPORTUNITIES
22.2 BASF SE
22.2.1 BUSINESS OVERVIEW
22.2.2 FINANCIAL OVERVIEW
22.2.3 PRODUCT OFFERINGS
22.2.4 KEY STRATEGIES
22.2.5 KEY STRENGTHS
22.2.6 KEY OPPORTUNITY
22.3 DSM
22.3.1 BUSINESS OVERVIEW
22.3.2 FINANCIAL OVERVIEW
22.3.3 PRODUCT OFFERINGS
22.3.4 KEY STRATEGY
22.3.5 KEY STRENGTHS
22.3.6 KEY OPPORTUNITY
22.4 AB ENZYMES
22.4.1 BUSINESS OVERVIEW
22.4.2 FINANCIAL OVERVIEW
22.4.3 PRODUCT OFFERINGS
22.4.4 KEY STRATEGIES
22.4.5 KEY STRENGTHS
22.4.6 KEY OPPORTUNITIES
22.5 NOVOZYMES
22.5.1 BUSINESS OVERVIEW
22.5.2 FINANCIAL OVERVIEW
22.5.3 PRODUCT OFFERINGS
22.5.4 KEY STRATEGIES
22.5.5 KEY STRENGTHS
22.5.6 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 CHR. HANSEN HOLDING A/S
23.1.1 COMPANY OVERVIEW
23.1.2 BUSINESS OVERVIEW
23.1.3 PRODUCT OFFERINGS
23.2 CODEXIS
23.2.1 COMPANY OVERVIEW
23.2.2 BUSINESS OVERVIEW
23.2.3 PRODUCT OFFERINGS
23.3 DYADIC INTERNATIONAL INC.
23.3.1 COMPANY OVERVIEW
23.3.2 BUSINESS OVERVIEW
23.3.3 PRODUCT OFFERINGS
23.4 AMANO ENZYME INC.
23.4.1 COMPANY OVERVIEW
23.4.2 BUSINESS OVERVIEW
23.4.3 PRODUCT OFFERINGS
23.5 BIOCATALYSTS
23.5.1 COMPANY OVERVIEW
23.5.2 BUSINESS OVERVIEW
23.5.3 PRODUCT OFFERINGS
23.6 NATURE BIOSCIENCE
23.6.1 COMPANY OVERVIEW
23.6.2 BUSINESS OVERVIEW
23.6.3 PRODUCT OFFERINGS
23.7 JOHNSON MATTHEY
23.7.1 COMPANY OVERVIEW
23.7.2 BUSINESS OVERVIEW
23.7.3 PRODUCT OFFERINGS
23.8 ADVANCED ENZYMES TECHNOLOGIES
23.8.1 COMPANY OVERVIEW
23.8.2 BUSINESS OVERVIEW
23.8.3 PRODUCT OFFERINGS
23.9 ZYMTRONIX, INC.
23.9.1 COMPANY OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 NUTRITECH
23.10.1 COMPANY OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH)
23.11.1 COMPANY OVERVIEW
23.11.2 BUSINESS OVERVIEW
23.11.3 PRODUCT OFFERINGS
23.12 AUMENZYMES
23.12.1 COMPANY OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 SOUFFLET GROUP
23.13.1 COMPANY OVERVIEW
23.13.2 BUSINESS OVERVIEW
23.13.3 PRODUCT OFFERINGS
23.14 IOSYNTH
23.14.1 COMPANY OVERVIEW
23.14.2 BUSINESS OVERVIEW
23.14.3 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY END-USER
25.1.1 PHARMACEUTICAL
25.1.2 FOOD & BEVERAGE
25.1.3 ANIMAL NUTRITION
25.1.4 HOUSEHOLD
25.1.5 OTHERS
25.2 MARKET BY TYPE
25.2.1 CARBOHYDRASES
25.2.2 PROTEASES
25.2.3 POLYMERASES & NUCLEASES
25.2.4 LIPASES
25.2.5 PHYTASES
25.2.6 OTHER
26 GEOGRAPHY
26.1 NORTH AMERICA
26.1.1 TYPE
26.1.2 END-USER
26.2 EUROPE
26.2.1 TYPE
26.2.2 END-USER
26.3 APAC
26.3.1 TYPE
26.3.2 END-USER
26.4 MIDDLE EAST & AFRICA
26.4.1 TYPE
26.4.2 END-USER
26.5 LATIN AMERICA
26.5.1 TYPE
26.5.2 END-USER
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL BIOCATALYSTS MARKET
EXHIBIT 2 BIOCATALYSTS MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 4 GLOBAL BIOCATALYSTS MARKET BY TYPE (% SHARE)
EXHIBIT 5 GLOBAL BIOCATALYSTS MARKET BY REGION (% SHARE)
EXHIBIT 6 PROPERTIES OF BIOCATALYSTS IN CHEMICAL REACTIONS
EXHIBIT 7 VALUE CHAIN ANALYSIS OF BIOCATALYSTS MARKET
EXHIBIT 8 GEOGRAPHICAL BREAKDOWN: SALE OF NEW MEDICINES 2015–2020
EXHIBIT 9 PHARMACEUTICAL R&D EXPENDITURE IN EUROPE & US 1990–2019 ($ MILLION)
EXHIBIT 10 GLOBAL BIOPHARMACEUTICAL R&D SPENDING ($ BILLION)
EXHIBIT 11 IMPACT OF INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
EXHIBIT 12 GLOBAL DRUG CONSUMPTION (NUMBER OF PEOPLE, $ MILLION)
EXHIBIT 13 IMPACT OF SOARING DEMAND FOR BIOFUEL
EXHIBIT 14 RISING PRICES OF CRUDE OIL PER BARREL ($)
EXHIBIT 15 IMPACT OF ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
EXHIBIT 16 IMPACT OF INCREASING USE OF CLEANING PRODUCTS
EXHIBIT 17 US LAUNDRY DETERGENT SALES BY PRODUCT TYPE 2021 (MILLION UNITS)
EXHIBIT 18 IMPACT OF INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
EXHIBIT 19 GLOBAL POPULATION 2016–2021 (BILLION UNITS)
EXHIBIT 20 IMPACT OF RISE IN DEMAND FOR PLANT-BASED PRODUCTS
EXHIBIT 21 PLANT-BASED FOOD SALES IN US 2020 ($ BILLION)
EXHIBIT 22 PLANT-BASED FOOD MARKET IN US
EXHIBIT 23 IMPACT OF TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
EXHIBIT 24 CONDITIONS REQUIRED FOR ENZYMOLOGY
EXHIBIT 25 IMPACT OF HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS
EXHIBIT 26 DESIGNED ENZYME PRODUCTION FACILITY’S ANNUAL OPERATING COST (%)
EXHIBIT 27 GLOBAL BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 28 FIVE FORCES ANALYSIS 2021
EXHIBIT 29 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 30 CLASSIFICATION OF BIOCATALYSTS MARKET BASED ON TYPE
EXHIBIT 31 GLOBAL CARBOHYDRASES-BASED BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 32 GLOBAL PROTEASES-BASED BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 GLOBAL LIPASE BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 35 GLOBAL PHYTASE BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 36 GLOBAL OTHER BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 37 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 38 CLASSIFICATION OF BIOCATALYSTS MARKET BASED ON END-USERS
EXHIBIT 39 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 40 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 41 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 42 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 GLOBAL OTHER BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 45 GEOGRAPHIC CONTRIBUTION & ABSOLUTE GROWTH OF BIOCATALYSTS MARKET
EXHIBIT 46 GEOGRAPHIC OVERVIEW OF BIOCATALYSTS MARKET
EXHIBIT 47 NORTH AMERICA BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 48 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 49 BIOCATALYSTS MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 50 BIOCATALYSTS MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 51 BIOCATALYSTS MARKET IN EUROPE 2021–2027 ($ MILLION)
EXHIBIT 52 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 53 BIOCATALYSTS MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 54 BIOCATALYSTS MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 55 BIOCATALYSTS MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 56 BIOCATALYSTS MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 57 BIOCATALYSTS MARKET IN REST OF EUROPE 2021–2027 ($ MILLION)
EXHIBIT 58 APAC BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 59 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 60 BIOCATALYSTS MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 61 BIOCATALYSTS MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 62 BIOCATALYSTS MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 63 BIOCATALYSTS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 64 BIOCATALYSTS MARKET IN REST OF APAC 2021–2027 ($ MILLION)
EXHIBIT 65 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 66 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 67 BIOCATALYSTS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 68 BIOCATALYSTS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 69 BIOCATALYSTS MARKET IN REST OF MEA 2021–2027 ($ MILLION)
EXHIBIT 70 LATIN AMERICA BIOCATALYSTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 71 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 72 BIOCATALYSTS MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 73 BIOCATALYSTS MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 74 BIOCATALYSTS MARKET IN REST OF MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)
EXHIBIT 75 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 76 SEGMENTAL REVENUE ($ BILLION)
EXHIBIT 77 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 78 SEGMENTAL REVENUE ($ BILLION)
EXHIBIT 79 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 80 FINANCIAL OVERVIEW ($ BILLION)
EXHIBIT 81 FINANCIAL OVERVIEW ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 PHARMACEUTICAL INDUSTRY IN EUROPE ($ MILLION)
TABLE 4 GLOBAL MEDICINES IN DEVELOPMENT (IN UNITS)
TABLE 5 REVENUE OF TOP 10 FOOD & BEVERAGES COMPANIES 2019–2020 ($ BILLION)
TABLE 6 CARBOHYDRASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 7 CARBOHYDRASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 8 PROTEASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 9 PROTEASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 10 POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 11 POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 12 LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 13 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 14 PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 15 PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 16 OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 17 GLOBAL OTHERS BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 18 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 19 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 20 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 21 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 22 ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 23 ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 24 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 25 HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 26 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 27 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 28 NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 29 NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 30 NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 31 NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 32 BIOCATALYSTS MARKET IN EUROPE BY TYPE 2021–2027 ($ MILLION)
TABLE 33 BIOCATALYSTS MARKET IN EUROPE BY TYPE 2021–2027 (%)
TABLE 34 BIOCATALYSTS MARKET IN EUROPE BY END-USER 2021–2027 ($ MILLION)
TABLE 35 BIOCATALYSTS MARKET IN EUROPE BY END-USER 2021–2027 (%)
TABLE 36 APAC BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 37 APAC BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 38 APAC BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 39 APAC BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 40 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 41 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 42 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 43 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER2021–2027 (%)
TABLE 44 LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 45 LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 46 LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 47 LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 48 DUPONT: MAJOR PRODUCT OFFERINGS
TABLE 49 BASF SE: MAJOR PRODUCT OFFERINGS
TABLE 50 DSM: MAJOR PRODUCT OFFERINGS
TABLE 51 AB ENZYMES: MAJOR PRODUCT OFFERINGS
TABLE 52 NOVOZYMES: MAJOR PRODUCT OFFERINGS
TABLE 53 CHR. HANSEN HOLDING A/S: BUSINESS & FINANCIAL OVERVIEW
TABLE 54 CHR HANSEN HOLDING A/S: MAJOR PRODUCT OFFERINGS
TABLE 55 CODEXIS: BUSINESS & FINANCIAL OVERVIEW
TABLE 56 CODEXIS: MAJOR PRODUCT OFFERINGS
TABLE 57 DYADIC INTERNATIONAL INC.: BUSINESS & FINANCIAL OVERVIEW
TABLE 58 DYADIC INTERNATIONAL INC.: MAJOR PRODUCT OFFERINGS
TABLE 59 AMANO ENZYME INC.: BUSINESS & FINANCIAL OVERVIEW
TABLE 60 AMANO ENZYME INC.: MAJOR PRODUCT OFFERINGS
TABLE 61 BIOCATALYSTS.: BUSINESS & FINANCIAL OVERVIEW
TABLE 62 BIOCATALYSTS: MAJOR PRODUCT OFFERINGS
TABLE 63 NATURE BIOSCIENCE: BUSINESS & FINANCIAL OVERVIEW
TABLE 64 NATURE BIOSCIENCE PVT LTD.: MAJOR PRODUCT OFFERINGS
TABLE 65 JOHNSON MATTHEY: BUSINESS & FINANCIAL OVERVIEW
TABLE 66 JOHNSON MATTHEY: MAJOR PRODUCT OFFERINGS
TABLE 67 ADVANCED ENZYMES TECHNOLOGIES: BUSINESS & FINANCIAL OVERVIEW
TABLE 68 ADVANCED ENZYME TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 69 ADVANCED ENZYME TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 70 NUTRITECH: MAJOR PRODUCT OFFERINGS
TABLE 71 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH): BUSINESS & FINANCIAL OVERVIEW
TABLE 72 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH): MAJOR PRODUCT OFFERINGS
TABLE 73 AUMENZYMES: MAJOR PRODUCT OFFERINGS
TABLE 74 SOUFFLET GROUP: BUSINESS & FINANCIAL OVERVIEW
TABLE 75 SOUFFLET GROUP: MAJOR PRODUCT OFFERINGS
TABLE 76 IOSYNTH: BUSINESS & FINANCIAL OVERVIEW
TABLE 77 IOSYNTH: MAJOR PRODUCT OFFERINGS
TABLE 78 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 79 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 80 GLOBAL FOOD & BEVERAGE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 81 GLOBAL FOOD & BEVERAGE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 82 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 83 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 84 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 85 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 86 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 87 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 88 GLOBAL CARBOHYDRASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 89 GLOBAL CARBOHYDRASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 90 GLOBAL PROTEASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 91 GLOBAL PROTEASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 92 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 93 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 94 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 95 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 96 GLOBAL PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 97 GLOBAL PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 98 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 99 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 100 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 101 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 102 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 103 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 104 GLOBAL EUROPE BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 105 GLOBAL EUROPE BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 106 GLOBAL EUROPE BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 107 GLOBAL EUROPE BIOCATALYSTS MARKET BY END-USE 2021–2027 (%)
TABLE 108 GLOBAL APAC BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 109 GLOBAL APAC BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 110 GLOBAL APAC BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 111 GLOBAL APAC BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 112 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 113 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 114 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 115 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
TABLE 116 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 ($ MILLION)
TABLE 117 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021–2027 (%)
TABLE 118 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 119 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
